- Home
- GPCR vs HDL Comparison
GPCR vs HDL Comparison
Compare GPCR & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- HDL
- Stock Information
- Founded
- GPCR 2016
- HDL 2016
- Country
- GPCR United States
- HDL Singapore
- Employees
- GPCR N/A
- HDL N/A
- Industry
- GPCR
- HDL Restaurants
- Sector
- GPCR
- HDL Consumer Discretionary
- Exchange
- GPCR Nasdaq
- HDL Nasdaq
- Market Cap
- GPCR 1.1B
- HDL 1.2B
- IPO Year
- GPCR 2023
- HDL 2024
- Fundamental
- Price
- GPCR $19.61
- HDL $20.40
- Analyst Decision
- GPCR Strong Buy
- HDL
- Analyst Count
- GPCR 9
- HDL 0
- Target Price
- GPCR $75.63
- HDL N/A
- AVG Volume (30 Days)
- GPCR 898.3K
- HDL 2.5K
- Earning Date
- GPCR 08-06-2025
- HDL 08-26-2025
- Dividend Yield
- GPCR N/A
- HDL N/A
- EPS Growth
- GPCR N/A
- HDL 110.82
- EPS
- GPCR N/A
- HDL 0.06
- Revenue
- GPCR N/A
- HDL $789,766,000.00
- Revenue This Year
- GPCR N/A
- HDL $14.91
- Revenue Next Year
- GPCR N/A
- HDL $12.41
- P/E Ratio
- GPCR N/A
- HDL $34.75
- Revenue Growth
- GPCR N/A
- HDL 10.91
- 52 Week Low
- GPCR $13.22
- HDL $14.18
- 52 Week High
- GPCR $45.37
- HDL $30.00
- Technical
- Relative Strength Index (RSI)
- GPCR 56.57
- HDL 57.86
- Support Level
- GPCR $18.39
- HDL $19.86
- Resistance Level
- GPCR $21.44
- HDL $20.46
- Average True Range (ATR)
- GPCR 1.18
- HDL 0.17
- MACD
- GPCR 0.31
- HDL 0.08
- Stochastic Oscillator
- GPCR 67.60
- HDL 96.19
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.